Skip to main content
10% off your first order — code WELCOME10 at checkout

Search

What Ambient Shipping Does to Lyophilised Material

What Ambient Shipping Does to Lyophilised Material

Last reviewed 9 August 2026

A box that has spent a summer afternoon in a delivery van arrives at the temperature of the van. That is not a fault in the arrangement; it is the arrangement. The useful question is not whether the vial got warm but what warmth does to a lyophilised solid — a materials question with a measured literature behind it. The same material back in solution is a separate question with separate kinetics.

“Ambient” is not a temperature, it is the absence of one

United States Pharmacopeia General Chapter <659> supplies the definitions, and the first settles the argument. Room temperature (also referred to as Ambient temperature): The temperature prevailing in a working environment. That is not a range. Ambient states that no temperature was imposed, so quoting it as a specification is a category error.

Storage temperature definitions, USP General Chapter <659>
TermDefinition
Controlled room temperatureThermostatically maintained, encompassing 20–25 °C, mean kinetic temperature not to exceed 25 °C
WarmBetween 30 °C and 40 °C
Excessive heatAbove 40 °C

Controlled room temperature is written to tolerate transit. Excursions between 15 °C and 30 °C are allowed, and then: Provided the mean kinetic temperature does not exceed 25°, transient spikes up to 40° are permitted as long as they do not exceed 24 h. Mean kinetic temperature is a weighted average giving disproportionate weight to the hot parts of a record, calculated as General Chapter <1079> sets out. A compendial storage condition is therefore not a line a thermometer must never cross: it is an integral over a period, with a cap on how long one excursion may last.

Check the current text before quoting it. Those definitions come from the Revision Bulletin official 1 May 2017; in 2026 USP proposed in Pharmacopeial Forum 52(4) to redefine controlled room temperature as 15–25 °C, comments open to 30 September 2026 — a consultation, not the operative text.

What has been measured inside ambient parcels

Schallenberger and colleagues (2016) placed data loggers inside parcels shipped from Montana to five warm-climate cities, collecting 72 usable one-way shipments and over 3,300 hours of data. They reported an average internal package temperature of 26.2 ± 2.3 °C, mirroring the external ambient temperature; that spikes above 40 °C were frequently observed; a maximum observed spike of 49.3 °C; and an extrapolated worst case of 52.9 °C for 12 hours and 14 minutes.

A shipment’s mean therefore sits close to controlled room temperature, while its peaks land in the range <659> calls excessive heat. That paper is a shipping record attached to a study of a demineralised bone matrix putty in a rodent model; it is cited only for the thermal data.

Why a lyophilisate behaves differently from a solution

Lai and Topp (1999) reviewed solid-state chemical stability of proteins and peptides, named the reactions that continue after drying — deamidation, peptide bond cleavage, oxidation, the Maillard reaction, β-elimination and aggregation — and identified the governing factors as temperature, moisture content, excipients and physical state. Freeze-drying does not stop chemistry; it slows it. Water was doing two jobs and drying withdraws both: it is a reactant, consumed by hydrolysis of the backbone and by deamidation at asparagine and glutamine residues, and it is a plasticiser, lowering the glass transition temperature of the amorphous phase and raising mobility within it.

The dominant variable is water, not temperature

Strickley and Anderson (1996) lyophilised insulin from pH 2–5 solutions, held the powders at a range of relative humidities at 35 °C, and measured water by Karl Fischer titration and degradation by HPLC. They reported that the degradation rate rose with water content well below the suspected glass transition, approaching the rate in solution at the 20–50 per cent water required to induce one, and concluded, of the pH 3–5 powders, that decomposition there is a water induced solid-state reaction accelerated by the plasticization effect of sorbed water.

Lai and colleagues (1999) ran the equivalent experiment on a short synthetic sequence — an asparagine-containing hexapeptide, Val-Tyr-Pro-Asn-Gly-Ala, lyophilised in poly(vinyl alcohol) and poly(vinyl pyrrolidone) matrices and then held at 50 °C. They reported that deamidation rate rose with water content and hence with decreasing glass transition temperature, and that deamidation was clearly evident in the glassy state; a companion paper varied glass transition with glycerol at constant water content in order to separate the two effects, and reported that water facilitates deamidation both by raising molecular mobility and by solvent and medium effects, and is itself consumed as a reactant in the subsequent breakdown of the cyclic imide. Yoshioka and Aso (2007) reached the general form of the same conclusion, and stated its limits: chemical stability in amorphous solids tracks global or local molecular mobility depending on the length scale of the reaction — except where the activation energy is high, or where water and excipient effects dominate, in which case it is largely independent of mobility.

The consequence is about the container, not the weather. Residual moisture in a sealed vial is set at secondary drying, and an intact closure holds it far more nearly constant than the weather does. What movement there is comes from the packaging rather than from transit. Pikal and Shah (1992) held two amorphous solids under butyl freeze-drying stoppers and reported moisture transferring from stopper to product towards an equilibrium set by the product, the fill mass and how the stopper had been treated; temperature governed the rate of approach — a half-time of roughly ten months at 5 °C against about four days at 40 °C — while the equilibrium value itself was independent of it. They found no evidence of transmission through the stopper. Donovan and colleagues (2007) reported the same dependence on how a closure had been processed and stored before use. Either way the endpoint was fixed before the parcel existed: warmth can bring a vial to it sooner, but not past it.

The number that matters is the glass transition

Duddu and Dal Monte (1997) compared two lyophilised formulations of one chimeric antibody: the sucrose formulation, glass transition approximately 59 °C, aggregated significantly at 60 °C, while the trehalose formulation at approximately 80 °C was stable there. Breen and colleagues (2001) fixed the range that figure occupies, reporting glass transitions from 80 °C down to 25 °C across residual moisture of 1 to 8 per cent. A well-dried cake therefore has a glass transition tens of degrees above anything a courier produces; a poorly dried one may sit at 25 °C. What matters is transit temperature against glass transition — a formulation property recorded on a certificate, not anything visible in the vial.

The arithmetic of a few warm days

Shalaev and colleagues (2023) reviewed temperature dependence of degradation in lyophiles and concluded that it follows the Arrhenius equation in most cases, that a break sometimes appears around the glass transition, and that most reported activation energies fall between 8 and 25 kcal/mol. Those endpoints give the factor by which a rate constant moves with temperature.

Rate multiplier implied by the reported activation-energy range
Temperature changeAt 8 kcal/molAt 25 kcal/mol
20 °C → 30 °C×1.6×4.1
5 °C → 20 °C×2.1×10.1
5 °C → 30 °C×3.3×41.7
−20 °C → 20 °C×8.8×881

Read it for shape rather than digits. Across ten or fifteen degrees the columns stay within a factor of five, so an estimate is useful even where the activation energy for a sequence is unknown; across forty degrees they diverge by two orders of magnitude, which is why extrapolating from freezer storage to a warm van yields a number carrying no information. Yoshioka, Miyazaki and Aso (2006) demonstrated that trap on lyophilised insulin, reporting significant bias where the rate was extrapolated from above the glass transition. The useful comparison is a duration one: three days at 20 °C rather than 5 °C consumes six to thirty days of equivalent refrigerated time. Transit is short, and shortness is most of the answer.

What the handling literature specifies

Bachem’s published handling literature answers the question in two places. Its frequently asked questions state that With few exceptions, the lyophilizates packed in sealed vials are sufficiently stable to tolerate 1-2 days at ambient temperature; its handling and storage guidelines state that They may be shipped at room temperature, and for short-term use, they may be stored in a refrigerator at 4 °C. Those guidelines specify a tightly closed container below −15 °C for long-term holding, and name the sequence-dependent exception: Peptides containing Asn, Gln, Met, Cys, and/or Trp have limited shelf lives. Those are the residues on which deamidation and oxidation run, so composition changes the answer — and composition sits in each compound’s library entry.

A worked example with published numbers

The clearest published case is a lyophilised synthetic peptide distributed as a measurement standard. The WHO 1st International Standard for Human C-peptide, NIBSC code 13/146, carries an assigned 8.64 µg of peptide per ampoule with phosphate salts and 2.5 mg of trehalose, sealed under nitrogen at −20 °C in the dark. Its instructions for use state that because of the inherent stability of lyophilized material, NIBSC may ship these materials at ambient temperature, and that accelerated degradation testing showed a predicted yearly loss of activity when stored at -20ºC of 0.07% and a predicted yearly loss of C-peptide content of 3.2% at 20ºC. Those percentages bracket the temperature step under discussion. They are stated for different parameters, so strictly they are not commensurable; read as comparable, the ratio implies an activation energy near 14 kcal/mol — inside the range above. The same document records hygroscopic: yes.

What the stability frameworks assume about transit

ICH Q1A(R2), Step 4 version of 6 February 2003, places transit inside the scope of a stability programme: The storage conditions and the lengths of studies chosen should be sufficient to cover storage, shipment, and subsequent use. Accelerated data, generated at 40 °C/75% RH for six months, can be used to evaluate the effect of short term excursions outside the label storage conditions (such as might occur during shipping).

The provision fitting material labelled for freezer storage is more specific. At −20 °C ± 5 °C there is no accelerated condition, so the guideline directs testing on a single batch at an elevated temperature (e.g., 5°C ± 3°C or 25°C ± 2°C)… to address the effect of short term excursions outside the proposed label storage condition. A framework prescribing 25 °C testing for freezer-labelled material expects freezer-labelled material to see 25 °C in transit. The EU Guidelines on Good Distribution Practice (2013/C 343/01) run alongside, requiring storage conditions to be maintained during transportation within the limits described by manufacturers or on the outer packaging — but those govern medicinal products, which research-grade material is not: a fact about the regulatory boundary, not a gap in it.

Checking a delivery

  1. Record the condition the parcel arrived in before opening it. If temperature matters to the work, measure it. “It felt warm” is not a temperature, and by then the box has equilibrated to the room.
  2. Inspect the sealed vial before breaking any seal, against a white background and then a light source, and photograph it. Once diluent goes in the evidence is gone.
  3. Assess the closure and the crimp first, separately from the cake. The seal is the failure that matters: an intact closure is what holds residual moisture nearly constant, and a compromised one lets the room in.
  4. Let a cold vial reach ambient temperature before opening it. Lyophilised peptide is hygroscopic, and opening a chilled container into a warm room condenses water onto the solid — the one way a handler reintroduces the variable the seal was holding steady.
  5. Distinguish loose powder from liquid. Powder displaced up the wall is a fragile cake fractured by vibration. A wet, glassy or sticky region, or a visibly slumped cake, is a temperature-history observation and the only appearance here saying the solid went somewhere it should not have.
  6. Keep the outer carton on until inspection. Kerwin and Remmele (2007) identified tryptophan, tyrosine, phenylalanine and cysteine as residues undergoing primary photo-oxidation; <659> names the control as a light-resistant container.

None of it changes the arithmetic, or the choice of diluent: concentration remains the mass of solid divided by the volume added, and that relation is what the reconstitution calculator computes. A delivery that arrived damaged rather than merely warm is a policy question, answered on the Delivery and Returns page; a question about one specific vial belongs on the contact page.

What a warm parcel does not settle

Everything a transit history raises resolves into a documentary question. Identity is a measured mass against the sequence; purity is a chromatographic figure; how much peptide is in the vial is net peptide content, after counterion and residual water; and residual moisture is a Karl Fischer number, entirely invisible. None is answered by how the box felt. NovoVita’s published position on purity is stated as a floor rather than a point value: Third-party tested at greater than 99% purity.

The honest summary is narrower than either answer usually given. A freeze-dried solid is not indifferent to temperature: Lai’s hexapeptide deamidated in the glassy state. Nor is a warm parcel a spoiled one: a lyophilised peptide standard is distributed at ambient on a published 3.2 per cent predicted annual loss at 20 °C. The dominant variable is water, the seal is what holds it nearly constant, and transit is short.

References

  1. United States Pharmacopeia. General Chapter <659>, Packaging and Storage Requirements. Revision Bulletin, official 1 May 2017; Temperature and Storage Definitions. Regulatory.
  2. ECA Academy. USP proposes to revise the definition of controlled room temperature in Chapter <659>. Report of the proposal published in Pharmacopeial Forum 52(4), comment period to 30 September 2026. Report of a proposal under consultation.
  3. International Council for Harmonisation. Stability Testing of New Drug Substances and Products, Q1A(R2). Current Step 4 version dated 6 February 2003; sections 2.2.7, 2.2.7.1 and 2.2.7.5. Regulatory.
  4. European Commission. Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01), Chapter 9, Transportation. Regulatory.
  5. National Institute for Biological Standards and Control. WHO International Standard, 1st International Standard for Human C-peptide, NIBSC code 13/146. Instructions for use, version 3.0, dated 27 October 2015; sections 5, 8, 9 and 15. Regulatory / reference-material documentation.
  6. Bachem. Handling and Storage Guidelines for Peptides, and Frequently Asked Questions. Manufacturer handling literature.
  7. Schallenberger M, Lovick H, Locke J, Meyer T, Juda G. The effect of temperature exposure during shipment on a commercially available demineralized bone matrix putty. Cell Tissue Bank. 2016;17(4):677–87. PMID 27562800. DOI 10.1007/s10561-016-9578-1. Shipping temperature record; material assessed in a rodent implantation model.
  8. Lai MC, Topp EM. Solid-state chemical stability of proteins and peptides. J Pharm Sci. 1999;88(5):489–500. PMID 10229638. DOI 10.1021/js980374e. Review.
  9. Yoshioka S, Aso Y. Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals. J Pharm Sci. 2007;96(5):960–81. PMID 17455355. DOI 10.1002/jps.20926. Review.
  10. Strickley RG, Anderson BD. Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions. Pharm Res. 1996;13(8):1142–53. PMID 8865303. DOI 10.1023/a:1016043715791. In vitro, lyophilised peptide hormone.
  11. Lai MC, Hageman MJ, Schowen RL, Borchardt RT, Topp EM. Chemical stability of peptides in polymers. 1. Effect of water on peptide deamidation in poly(vinyl alcohol) and poly(vinyl pyrrolidone) matrixes. J Pharm Sci. 1999;88(10):1073–80. PMID 10514358. DOI 10.1021/js980227g. In vitro, synthetic hexapeptide.
  12. Lai MC, Hageman MJ, Schowen RL, Borchardt RT, Laird BB, Topp EM. Chemical stability of peptides in polymers. 2. Discriminating between solvent and plasticizing effects of water on peptide deamidation in poly(vinylpyrrolidone). J Pharm Sci. 1999;88(10):1081–9. PMID 10514359. DOI 10.1021/js9802289. In vitro, synthetic hexapeptide.
  13. Pikal MJ, Shah S. Moisture transfer from stopper to product and resulting stability implications. Dev Biol Stand. 1992;74:165–77; discussion 177–9. PMID 1592166. In vitro, amorphous solids under butyl freeze-drying closures.
  14. Donovan PD, Corvari V, Burton MD, Rajagopalan N. Effect of stopper processing conditions on moisture content and ramifications for lyophilized products: comparison of “low” and “high” moisture uptake stoppers. PDA J Pharm Sci Technol. 2007;61(1):51–8. PMID 17390704. In vitro, elastomeric closure moisture study.
  15. Duddu SP, Dal Monte PR. Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody. Pharm Res. 1997;14(5):591–5. PMID 9165528. DOI 10.1023/a:1012144810067. In vitro, protein formulation.
  16. Breen ED, Curley JG, Overcashier DE, Hsu CC, Shire SJ. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm Res. 2001;18(9):1345–53. PMID 11683251. DOI 10.1023/a:1013054431517. In vitro, protein formulation.
  17. Shalaev E, Ohtake S, Moussa EM, Searles J, Nail S, Roberts CJ. Accelerated storage for shelf-life prediction of lyophiles: temperature dependence of degradation of amorphous small molecular weight drugs and proteins. J Pharm Sci. 2023;112(6):1509–22. PMID 36796635. DOI 10.1016/j.xphs.2023.02.008. Review.
  18. Yoshioka S, Miyazaki T, Aso Y. Degradation rate of lyophilized insulin, exhibiting an apparent Arrhenius behavior around glass transition temperature regardless of significant contribution of molecular mobility. J Pharm Sci. 2006;95(12):2684–91. PMID 16892208. DOI 10.1002/jps.20689. In vitro, lyophilised peptide hormone.
  19. Kerwin BA, Remmele RL Jr. Protect from light: photodegradation and protein biologics. J Pharm Sci. 2007;96(6):1468–79. PMID 17230445. DOI 10.1002/jps.20815. Review.
Back to Top
Product has been added to your cart
Compare (0)